Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Artificial Heart Market: By Type, By Purpose, By Energy and Region Forecast 2019-2030
Artificial Heart Market: By Type, By Purpose, By Energy and Region Forecast 2019-2030
Artificial Heart Market size was valued at 2.82 billion in 2023 and is poised to grow at a CAGR of 15.3% from 2024 to 2030. Limited availability of donors, on spot availability of fresh organs had limited the rate of orthotropic heart transplantations. High chances of non-suitability of available organs due to blood groups, age and high risk of transplantation due to high pulmonary vascular resistance of patients leads in increasing number of patients for organs than with donors which leads to high increase in demand for artificial heart devices.
Although high cost procedures, stringent regulatory scenarios are restraining the market in some cases. Global market is surging owing to frequent acquisitions and launchings by the market players. For instance, In August 2019 researchers at The University of Birmingham have developed a device that could improve care for patients with artificial heart pumps. Also non-blood contacting devices are developing which will enhance the market.
Study Period
2024-2030Base Year
2023CAGR
15.3%Largest Market
North AmericaFastest Growing Market
North America
These devices are used mostly in cases of advanced cardiovascular disease patients in whom their biological heart is damaged either partially or completely and is in non-favorable condition for orthotropic heart transplantation. These are most prominently using in acute biventricular dysfunction where one ventricle of heart is replaced by prosthetic heart. Also widely spreading in allograft coronary diseases. These devices are highly efficient and they do not possess any side effects or incompatibilities with the patient body.
North America accounted for larger revenue share in global artificial heart market with a considerable CAGR. The growth in this region can be attributed to the presence of large cardiac disease patients and more advanced treatment facilities. According to center for disease control & prevention 2015 over 630,000 Americans died of heart diseases which is one fourth of country population and in 2016, 1.42 billion market occurred in North American region alone. alone spending around 800 million USD on cardiac treatments and researches. Countries like USA and Canada with advanced technologies, great funding for research places this region on top of the list.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market CAGR |
15.3% |
|
By Type |
|
|
By Purpose |
|
|
By Energy |
|
|
By Region |
|
Download Free Sample Report
The global artificial heart market size was valued at US$ 2.82 billion in 2023 and is projected to grow at a significant CAGR of 15.3% from 2024-2030.
North America is the fastest-growing for artificial heart market
The market key players are: Abbott Laboratories ABIOMED Berlin heart BIVACOR Inc. CARMAT Cleveland Heart Inc. CRYO life Inc. JARVIK Heart Inc. LIVA-NOVA PLC MYLVAD ON-X LIFE TECHNOLOGIES RELAINT Heart Inc. SYNCARDIA systems Thoratec corporation
| 1. Executive Summary |
| 2. Global Artificial Heart Market Introduction |
| 2.1. Global Artificial Heart Market Taxonomy |
| 2.2. Global Artificial Heart Market Definitions |
| 2.2.1. By Type |
| 2.2.2. By End User |
| 2.2.3. By Region |
| 3. Global Artificial Heart Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Artificial Heart Market Dynamic Factors - Impact Analysis |
| 3.6. Global Artificial Heart Market Competition Landscape |
| 4. Global Artificial Heart Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Artificial Heart Market, By Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1. Heart-Lung Machine |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Mechanical Heart |
| 5.2.1. Total Artificial Hearts |
| 5.2.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.1.3. Market Opportunity Analysis |
| 5.2.2. Ventricular Assist Devices (VADs) |
| 5.2.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.2.3. Market Opportunity Analysis |
| 6. Global Artificial Heart Market, By End User, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.1. Hospitals & Clinics |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Specialty Centers |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Others |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Global Artificial Heart Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia-Pacific |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Latin America |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Middle East and Africa |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Global Artificial Heart Market - Opportunity Analysis Index, By Type, End User, and Region, 2024 - 2030 |
| 8. North America Artificial Heart Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1. Heart-Lung Machine |
| 8.1.2. Mechanical Heart |
| 8.1.2.1. Total Artificial Hearts |
| 8.1.2.2. Ventricular Assist Devices (VADs) |
| 8.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1. Hospitals & Clinics |
| 8.2.2. Specialty Centers |
| 8.2.3. Others |
| 8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 8.3.1. USA |
| 8.3.2. Canada |
| 8.4. North America Artificial Heart Market - Opportunity Analysis Index, By Type, End User, and Country, 2024 - 2030 |
| 8.5. North America Artificial Heart Market Dynamics Trends |
| 9. Europe Artificial Heart Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Heart-Lung Machine |
| 9.1.2. Mechanical Heart |
| 9.1.2.1. Total Artificial Hearts |
| 9.1.2.2. Ventricular Assist Devices (VADs) |
| 9.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1. Hospitals & Clinics |
| 9.2.2. Specialty Centers |
| 9.2.3. Others |
| 9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 9.3.1. Germany |
| 9.3.2. UK |
| 9.3.3. France |
| 9.3.4. Spain |
| 9.3.5. Italy |
| 9.3.6. Russia |
| 9.3.7. Rest of Europe |
| 9.4. Europe Artificial Heart Market - Opportunity Analysis Index, By Type, End User, and Country, 2024 - 2030 |
| 9.5. Europe Artificial Heart Market Dynamics Trends |
| 10. Asia-Pacific Artificial Heart Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 10.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Heart-Lung Machine |
| 10.1.2. Mechanical Heart |
| 10.1.2.1. Total Artificial Hearts |
| 10.1.2.2. Ventricular Assist Devices (VADs) |
| 10.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Hospitals & Clinics |
| 10.2.2. Specialty Centers |
| 10.2.3. Others |
| 10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. China |
| 10.3.2. India |
| 10.3.3. Japan |
| 10.3.4. ASEAN |
| 10.3.5. Australia & New Zealand |
| 10.3.6. Rest of Asia-Pacific |
| 10.4. Asia-Pacific Artificial Heart Market - Opportunity Analysis Index, By Type, End User, and Country, 2024 - 2030 |
| 10.5. Asia-Pacific Artificial Heart Market Dynamics Trends |
| 11. Latin America Artificial Heart Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 11.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Heart-Lung Machine |
| 11.1.2. Mechanical Heart |
| 11.1.2.1. Total Artificial Hearts |
| 11.1.2.2. Ventricular Assist Devices (VADs) |
| 11.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Hospitals & Clinics |
| 11.2.2. Specialty Centers |
| 11.2.3. Others |
| 11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Brazil |
| 11.3.2. Mexico |
| 11.3.3. Argentina |
| 11.3.4. Rest of Latin America |
| 11.4. Latin America Artificial Heart Market - Opportunity Analysis Index, By Type, End User, and Country, 2024 - 2030 |
| 11.5. Latin America Artificial Heart Market Dynamics Trends |
| 12. Middle East and Africa Artificial Heart Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 12.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Heart-Lung Machine |
| 12.1.2. Mechanical Heart |
| 12.1.2.1. Total Artificial Hearts |
| 12.1.2.2. Ventricular Assist Devices (VADs) |
| 12.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Hospitals & Clinics |
| 12.2.2. Specialty Centers |
| 12.2.3. Others |
| 12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Gulf Cooperation Council (GCC) Countries |
| 12.3.2. Israel |
| 12.3.3. South Africa |
| 12.3.4. Rest of MEA |
| 12.4. MEA Artificial Heart Market - Opportunity Analysis Index, By Type, End User, and Country, 2024 - 2030 |
| 12.5. MEA Artificial Heart Market Dynamics Trends |
| 13. Competition Landscape |
| 13.1. Strategic Dashboard of Top Market Players |
| 13.2. Company Profiles (Introduction, Financial Analysis, Type Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 13.2.1. Thoratec Corporation |
| 13.2.2. SynCardia Systems LLC |
| 13.2.3. Edwards Lifesciences Corporation |
| 13.2.4. CryoLife Inc. |
| 13.2.5. Cleveland Heart Inc. |
| 13.2.6. CARMAT, |
| 13.2.7. BiVACOR Inc. |
| 13.2.8. ABIOMED |
| 13.2.9. Abbott |
| 14. Research Methodology |
| 15. Key Assumptions and Acronyms |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.